221 related articles for article (PubMed ID: 22161683)
1. Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts.
Zerboni L; Arvin A
J Neurovirol; 2011 Dec; 17(6):570-7. PubMed ID: 22161683
[TBL] [Abstract][Full Text] [Related]
2. Varicella-zoster virus infection of human dorsal root ganglia in vivo.
Zerboni L; Ku CC; Jones CD; Zehnder JL; Arvin AM
Proc Natl Acad Sci U S A; 2005 May; 102(18):6490-5. PubMed ID: 15851670
[TBL] [Abstract][Full Text] [Related]
3. Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo.
Zerboni L; Arvin A
PLoS Pathog; 2015 Jun; 11(6):e1004989. PubMed ID: 26090802
[TBL] [Abstract][Full Text] [Related]
4. Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts.
Zerboni L; Reichelt M; Arvin A
Curr Top Microbiol Immunol; 2010; 342():255-76. PubMed ID: 20225014
[TBL] [Abstract][Full Text] [Related]
5. Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis.
Zerboni L; Berarducci B; Rajamani J; Jones CD; Zehnder JL; Arvin A
J Virol; 2011 Jan; 85(1):98-111. PubMed ID: 20962081
[TBL] [Abstract][Full Text] [Related]
6. Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I.
Zerboni L; Reichelt M; Jones CD; Zehnder JL; Ito H; Arvin AM
Proc Natl Acad Sci U S A; 2007 Aug; 104(35):14086-91. PubMed ID: 17709745
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia.
Reichelt M; Zerboni L; Arvin AM
J Virol; 2008 Apr; 82(8):3971-83. PubMed ID: 18256143
[TBL] [Abstract][Full Text] [Related]
8. Varicella-zoster virus glycoprotein I is essential for spread in dorsal root ganglia and facilitates axonal localization of structural virion components in neuronal cultures.
Christensen J; Steain M; Slobedman B; Abendroth A
J Virol; 2013 Dec; 87(24):13719-28. PubMed ID: 24109230
[TBL] [Abstract][Full Text] [Related]
9. Molecular studies of the Oka varicella vaccine.
Quinlivan M; Breuer J; Schmid DS
Expert Rev Vaccines; 2011 Sep; 10(9):1321-36. PubMed ID: 21919621
[TBL] [Abstract][Full Text] [Related]
10. The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo.
Baiker A; Bagowski C; Ito H; Sommer M; Zerboni L; Fabel K; Hay J; Ruyechan W; Arvin AM
J Virol; 2004 Feb; 78(3):1181-94. PubMed ID: 14722273
[TBL] [Abstract][Full Text] [Related]
11. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
Arvin AM
Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus 1 tropism for human sensory ganglion neurons in the severe combined immunodeficiency mouse model of neuropathogenesis.
Zerboni L; Che X; Reichelt M; Qiao Y; Gu H; Arvin A
J Virol; 2013 Mar; 87(5):2791-802. PubMed ID: 23269807
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.
Moffat JF; Zerboni L; Kinchington PR; Grose C; Kaneshima H; Arvin AM
J Virol; 1998 Feb; 72(2):965-74. PubMed ID: 9444989
[TBL] [Abstract][Full Text] [Related]
14. Varicella-Zoster Virus ORF63 Protects Human Neuronal and Keratinocyte Cell Lines from Apoptosis and Changes Its Localization upon Apoptosis Induction.
Gerada C; Steain M; McSharry BP; Slobedman B; Abendroth A
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593042
[TBL] [Abstract][Full Text] [Related]
15. Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.
Berarducci B; Rajamani J; Zerboni L; Che X; Sommer M; Arvin AM
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):282-7. PubMed ID: 19966293
[TBL] [Abstract][Full Text] [Related]
16. Varicella-zoster virus human ganglionic latency: a current summary.
Kennedy PG; Cohrs RJ
J Neurovirol; 2010 Nov; 16(6):411-8. PubMed ID: 20874010
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse.
Besser J; Sommer MH; Zerboni L; Bagowski CP; Ito H; Moffat J; Ku CC; Arvin AM
J Virol; 2003 May; 77(10):5964-74. PubMed ID: 12719588
[TBL] [Abstract][Full Text] [Related]
18. Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.
Arvin AM; Moffat JF; Sommer M; Oliver S; Che X; Vleck S; Zerboni L; Ku CC
Curr Top Microbiol Immunol; 2010; 342():189-209. PubMed ID: 20397071
[TBL] [Abstract][Full Text] [Related]
19. Varicella zoster virus in human and rat tissue specimens.
Annunziato PW; Lungu O; Panagiotidis C
Arch Virol Suppl; 2001; (17):135-42. PubMed ID: 11339542
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of varicella zoster virus pathogenesis.
Zerboni L; Sen N; Oliver SL; Arvin AM
Nat Rev Microbiol; 2014 Mar; 12(3):197-210. PubMed ID: 24509782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
